Ruixiang Tang
277 West Yanta Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "New insights into long non-coding RNAs in non-small cell lung cancer" [Biomed. Pharmacother. 131 (November) (2020) 110775].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 01, 2020
Evaluation of Hippo Pathway and CD133 in Radiation Resistance in Small-Cell Lung Cancer.
Journal: Journal of oncology
Published: July 18, 2020
New insights into long non-coding RNAs in non-small cell lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2020
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors.
Journal: Frontiers in pharmacology
Published: April 20, 2020
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Journal: BMC medical genomics
Published: January 15, 2020
Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
Journal: Combinatorial chemistry & high throughput screening
Published: December 02, 2019
YAP1 promotes multidrug resistance of small cell lung cancer by CD74-related signaling pathways.
Journal: Cancer medicine
Published: May 28, 2019
TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495.
Journal: Biochemical and biophysical research communications
Published: February 19, 2017
WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway.
Journal: British journal of cancer
Published: February 29, 2016
Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: January 26, 2015
Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Journal: Experimental and molecular pathology
Published: December 03, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026